AQST
AQST
NASDAQ · Pharmaceuticals

Aquestive Therapeutics Inc

$3.61
-0.05 (-1.37%)
As of Nov 8, 10:29 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +617.5% upside
Low Target $17.61
Average Target $25.90
High Target $34.98
Current Price $3.61
Current
$3.61
Target
$25.90
$17.61 $25.90 avg $34.98
Scenario Analysis
Bear Case
$17.61
387.8%
Low target
Base Case
$25.90
+617.5%
Avg target
Bull Case
$34.98
+869.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$6.85
-47.3% from high
52-Week Low
$2.93
+23.2% from low
Target vs 52W High
$25.90
+278.1% vs high
Next Earnings Report
Nov 9, 2026 · After Market Close
Today
EPS Est: $-0.12
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%